Exenatide Once Weekly vs. Liraglutide Daily for Type 2 Diabetes
Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes
Background
Despite lifestyle modifications and existing oral antidiabetic medications, many patients with Type 2 Diabetes Mellitus struggle to achieve optimal glycemic control. GLP-1 receptor agonists are a highly effective class of treatments for this chronic metabolic condition, offering benefits beyond blood glucose reduction. However, there has been a significant knowledge gap regarding direct, head-to-head comparisons between exenatide once weekly and liraglutide once daily, making it challenging for clinicians to choose the most appropriate therapy for their patients.